A single backmutation in the human kIV framework of a previously unsuccessfully humanized antibody restores the binding activity and increases the secretion in cos cells.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Molecular Immunology

• Publication date

  1999-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0161-5890(99)00087-5PMID 10593510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules.

  1998cited by this paper
• Antibody engineering: a practical approach

  1997cited by this paper
• Variable domain structure of kappaIV human light chain Len: high homology to the murine light chain McPC603.

  1997cited by this paper
• A Humanized Form of a CD4-Specific Monoclonal Antibody Exhibits Decreased Antigenicity and Prolonged Plasma Half-Life in Rhesus Monkeys While Retaining Its Unique Biological and Antiviral Properties

  1997cited by this paper
• Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.

  1997cited by this paper
• The crystal structure of a Fab fragment to the melanoma-associated GD2 ganglioside.

  1997cited by this paper
• Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity.

  1997cited by this paper
• Humanization of a mouse antibody against human alpha-4 integrin: A potential therapeutic for the treatment of multiple sclerosis

  1997cited by this paper
• Kabat database of sequences of proteins of immunological interest

  1996cited by this paper
• A humanized antibody with specificity for hepatitis B surface antigen

  1996cited by this paper
• Accessing the Kabat antibody sequence database by computer

  1996cited by this paper
• Generation and Characterization of a Humanized Antibody with Specificity for preS2 Surface Antigen of Hepatitis B Virus

  1996cited by this paper
• Engineered turns of a recombinant antibody improve its in vivo folding.

  1995cited by this paper
• Identification of framework residues required to restore antigen binding during reshaping of a monoclonal antibody against the glycoprotein gB of human cytomegalovirus.

  1995cited by this paper
• Generation, Characterization, and in Vivo Studies of Humanized Anticarcinoma Antibody CC49

  1995cited by this paper
• Sequence statistics reliably predict stabilizing mutations in a protein domain.

  1994cited by this paper
• Humanization of a mouse anti-human interleukin-6 receptor antibody comparing two methods for selecting human framework regions.

  1994cited by this paper
• Humanization of 60.3, an anti-CD18 antibody; importance of the L2 loop.

  1994cited by this paper
• X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.

  1993cited by this paper
• Optimal humanization of 1B4, an anti-CD18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequences.

  1993cited by this paper
• Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies.

  1993cited by this paper
• Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

  1992cited by this paper
• Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

  1992cited by this paper
• Reshaping a therapeutic CD4 antibody.

  1991cited by this paper
• Polymerase chain reaction facilitates the cloning, CDR-grafting, and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins.

  1991cited by this paper
• Humanized antibodies for antiviral therapy.

  1991cited by this paper
• Construction of reshaped human antibodies with HIV-neutralizing activity

  1991cited by this paper
• Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.

  1991cited by this paper
• Conformations of immunoglobulin hypervariable regions

  1989cited by this paper
• Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.

  1989cited by this paper
• Canonical structures for the hypervariable regions of immunoglobulins.

  1987cited by this paper
• Identification and characterization of two novel lymphocyte function-associated antigens, L24 and L25.

  1987cited by this paper
• Relationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA autoantibodies.

  1987cited by this paper
• Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A.

  1985cited by this paper
• Domain association in immunoglobulin molecules. The packing of variable domains.

  1985cited by this paper
• Subgroup IV of human immunoglobulin K light chains is encoded by a single germline gene.

  1985cited by this paper
• Amino acid sequence of the variable region of M149 mouse myeloma light chain: comparison with the nucleotide sequence of K2 and K3 clones.

  1980cited by this paper
• Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments.

  1980cited by this paper
• Die Primärstruktur einer monoklonalen Immunglobulin-L-Kette der Subgruppe IV vom κ-Typ (Bence-Jones-Protein Len.)

  1975cited by this paper
• Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI.

  1974cited by this paper

• Computational optimization of antibody humanness and stability by systematic energy-based ranking

  2023cites this paper
• Reliable energy-based antibody humanization and stabilization

  2022cites this paper
• In Pursuit of Stability Enhancement of a Prostate Cancer Targeting Antibody Derived from a Transgenic Animal Platform

  2020cites this paper
• Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application

  2015cites this paper
• Engineering Antibodies for Cancer Therapy

  2011cites this paper
• Antibody expression and production

  2011cites this paper
• Protein Sequence and Structure Analysis of Antibody Variable Domains

  2010cites this paper
• Humanization of high affinity anti-HBs antibody by using human consensus sequence and modification of selected minimal positional template and packing residues.

  2009cites this paper
• Framework shuffling of antibodies to reduce immunogenicity and manipulate functional and biophysical properties.

  2007cites this paper
• Engineering stability into Escherichia coli secreted Fabs leads to increased functional expression.

  2006cites this paper
• Latest technologies for the enhancement of antibody affinity.

  2006cites this paper
• Developing high affinity antibodies as diagnostics

  2006cites this paper
• Procede permettant d’ameliorer un anticorps

  2006cites this paper
• Engineering therapeutic antibody fragments targeting the anthrax toxin

  2005cites this paper
• Design of humanized antibodies: from anti-Tac to Zenapax.

  2005cites this paper
• Enantioselective antibody fragments

  2004cites this paper
• The cloning, characterisation and engineering of an IGF-I-BINDING single chain Fv

  2004cites this paper
• Nevanen Enantioselective antibody fragments

  2004cites this paper
• Restoration of Ig Secretion: Mutation of Germline-Encoded Residues in T15L Chains Leads to Secretion of Free Light Chains and Assembled Antibody Complexes Bearing Secretion-Impaired Heavy Chains 1

  2003cites this paper
• Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigen.

  2003cites this paper
• Therapeutic antibodies for human diseases at the dawn of the twenty-first century

  2003cites this paper
• Secretion-Impaired Heavy Chains Assembled Antibody Complexes Bearing Leads to Secretion of Free Light Chains and Germline-Encoded Residues in T 15 L Chains Restoration of Ig Secretion : Mutation of Rittenberg

  2003cites this paper
• Functional aspects of co‐variant surface charges in an antibody fragment

  2002cites this paper
• The development and applications of polyclonal and monoclonal antibodies for the detection of illicit drugs in saliva samples

  2002cites this paper
• Combination of hu-PBL-SCID mice and scFv phage display library, an effective alternative for hu-mAb production

  2001cites this paper